Zhu, J.Q., Zhong, W.Z., Zhang, G.C., et al. (2008) Better Sur-vival with EGFR Exon 19 than Exon 2 Mutations in Gefltinlb-Treated Non-Small Cell Lung Cancer Patients Is Due to Differential Inhibition of Downstream Signals. Cancer Letters, 265, 307-317.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享